Cytek Biosciences Reports Second Quarter 2023 Financial Resu

FREMONT, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30, 2023.

Related Keywords

Fremont , California , United States , China , Stephanie Olsen , Cytek Bioscience , Pauld Goodson , Cytek Biosciences , Wenbin Jiang , Twitter , Exchange Commission , Cytek Biosciences Inc , Securities Exchange , Linkedin , European Union , Lages Associates , Biosciences Inc , Luminex Corporation , Cytek Aurora Cell Sorter , Full Spectrum Profiling , Northern Lights , Regarding Use , Private Securities Litigation Reform Act , Securities Act , Securities Exchange Act , Cytek Bioscience Quarterly Report , Cytek Bioscience Annual Report , Relations Contact , Region ,